The product information provided in this site is intended for residents of the United States.

A safe way to manage your IBS-D

EnteraGam® is a prescription medical food product for the dietary management of intestinal or bowel problems (also called enteropathy), such as diarrhea-predominant irritable bowel syndrome (IBS-D) and inflammatory bowel disease (IBD).

EnteraGam® works differently

EnteraGam® uniquely binds microbial components, such as toxins that bacteria release, that upset the intestinal environment. This helps prevent them from penetrating the lining of the intestine, which can cause chronic loose and frequent stools in people with IBS or IBD.1,2

EnteraGam® Patient Support & Pharmacy Services

EnteraGam® offers prescription co-pay savings vouchers, personalized pharmacy services, and helpful information you can benefit from.

Learn more at The Hub


  1. Petschow BW, Burnett B, Shaw AL, Weaver EM, Klein GL. Serum-derived bovine immunoglobulin/protein isolate: postulated mechanism of action for management of enteropathy. Clin Exp Gastroenterol. 2014;7:181-190.
  2. Gasbarrini A, Lauritano EC, Garcovich M, Sparano L, Gasbarrini G. New insights into the pathophysiology of IBS: intestinal microflora, gas production and gut motility. Eur Rev Med Pharmacol Sci. 2008;12 Suppl 1:111-117.

Intended Use

EnteraGam® (serum-derived bovine immunoglobulin/protein isolate, SBI) is a prescription medical food product intended to provide for distinctive nutritional requirements that are unique for the clinical dietary management of specific intestinal disorders [e.g., in irritable bowel syndrome with diarrhea (IBS-D), inflammatory bowel disease (IBD), and HIV-associated enteropathy]. EnteraGam®, as a medical food, must be used under physician supervision.

Important Safety Information:

EnteraGam® contains beef protein; therefore, patients who have an allergy to beef or any component of EnteraGam® should not take this product. The most commonly reported adverse events in clinical studies (incidence of 2%-5%) include mild nausea, constipation, stomach cramps, headache, and increased urination. EnteraGam® has not been studied in pregnant or nursing women, so the choice to administer EnteraGam® for patients who are pregnant or nursing is at the clinical discretion of the prescribing physician.

EnteraGam® does not contain any milk products such as lactose, casein, or whey. It is gluten-free, dye-free, and soy-free. EnteraGam® contains 5 g of SBI and other ingredients such as dextrose (5 g) and trace amounts of sunflower lecithin.

Please see full Prescribing Information including contraindications.

To report suspected adverse events, please contact Entera Health, Inc. at 1-855-4ENTERA (1-855-436-8372).

You are encouraged to report negative side effects to your doctor and the FDA.

Visit or call 1-800-FDA-1088 (1-800-332-1088).